Abstract TH172: Impact of Blood Pressure Optimization on PREVENT-Based ASCVD Risk Classification and Treatment Indications: National Estimates From NHANES
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Severyn Kushmeliuk und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background: The 2026 ACC/AHA Dyslipidemia Guidelines introduced the AHA PREVENT equations as the preferred risk estimator for lipid lowering therapy eligibility (LLT), establishing 10-year thresholds of 3-5% (COR 2a) and ≥5% (COR 1) and a 30-year threshold of ≥10% for young adults (age 30-59). Because PREVENT incorporates systolic blood pressure (SBP) as a structural covariate, BP optimization may independently reclassify adults across these thresholds. We examined SBP
Zitieren
APA
Kushmeliuk, S., Shaik, A., Prakash, Y., Kayani, J., Malick, W., Bryant, K., & Dhaybi, O. A. (2026). Abstract TH172: Impact of Blood Pressure Optimization on PREVENT-Based ASCVD Risk Classification and Treatment Indications: National Estimates From NHANES. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th172
Vancouver
Kushmeliuk S, Shaik A, Prakash Y, Kayani J, Malick W, Bryant K, et al. Abstract TH172: Impact of Blood Pressure Optimization on PREVENT-Based ASCVD Risk Classification and Treatment Indications: National Estimates From NHANES. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th172
BibTeX
@article{Kushmeliuk2026,
author = {Kushmeliuk, Severyn and Shaik, Aleesha and Prakash, Yash and Kayani, Jehanzeb and Malick, Waqas and Bryant, Kelsey and Dhaybi, Omar Al},
title = {Abstract TH172: Impact of Blood Pressure Optimization on PREVENT-Based ASCVD Risk Classification and Treatment Indications: National Estimates From NHANES},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th172}
}
EUVIMED